C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/62 (2006.01) A61K 38/17 (2006.01) C07K 14/705 (2006.01) C07K 14/71 (2006.01) C07K 19/00 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2377489
Chimeric cell-surface proteins are described which may be used in the selective induction of apoptosis in particular target cell types such as cancer cells in vivo or in vitro. Nucleic acid sequences encoding such proteins and methods of use relating to cancer and other therapies are provided.
L'invention concerne des protéines chimères de surface cellulaire qui peuvent être utilisées pour induire, de manière sélective, l'apoptose dans des types de cellules cibles particulières, comme des cellules cancéreuses in vivo ou in vitro. L'invention traite aussi des séquences d'acides nucléiques codant ces protéines et de procédés d'utilisation pour soigner le cancer et pouvant être utilisés pour d'autres thérapies.
Angiogene Pharmaceuticals Ltd.
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Chimeric proteins mediating targeted apoptosis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Chimeric proteins mediating targeted apoptosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chimeric proteins mediating targeted apoptosis will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1997688